Senores Pharmaceuticals Forms Joint Venture Amerisyn, LLC
Senores Pharmaceuticals Limited announced the formation of a joint venture company, Amerisyn, LLC, in North Carolina, USA, on April 4, 2026. The joint venture was established through an Operating Agreement dated April 2, 2026, involving the company’s wholly owned subsidiary, Senores Pharmaceuticals, Inc., USA ("SPI").SPI has subscribed to 70% of the membership interest in Amerisyn, LLC, which has become a step-down subsidiary of Senores Pharmaceuticals Limited. Amerisyn, LLC was formed on March 5, 2026, and is based in the United States of America.Table: Details of Amerisyn, LLCParticularsDescriptionName of the Target CompanyAmerisyn, LLCTurnoverNot applicable as...